These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 19997980)

  • 1. Non-functional neuroendocrine carcinoma of the pancreas: incidence, tumor biology, and outcomes in 2,158 patients.
    Franko J; Feng W; Yip L; Genovese E; Moser AJ
    J Gastrointest Surg; 2010 Mar; 14(3):541-8. PubMed ID: 19997980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical resection of the primary tumor leads to prolonged survival in metastatic pancreatic neuroendocrine carcinoma.
    Feng T; Lv W; Yuan M; Shi Z; Zhong H; Ling S
    World J Surg Oncol; 2019 Mar; 17(1):54. PubMed ID: 30898132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes and prognostic factors in neuroendocrine carcinomas of the pancreas: Morphology matters.
    Crippa S; Partelli S; Bassi C; Berardi R; Capelli P; Scarpa A; Zamboni G; Falconi M
    Surgery; 2016 Mar; 159(3):862-71. PubMed ID: 26602841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
    Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
    Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The conundrum of < 2-cm pancreatic neuroendocrine tumors: A preoperative risk score to predict lymph node metastases and guide surgical management.
    Lopez-Aguiar AG; Ethun CG; Zaidi MY; Rocha FG; Poultsides GA; Dillhoff M; Fields RC; Idrees K; Cho CS; Abbott DE; Cardona K; Maithel SK
    Surgery; 2019 Jul; 166(1):15-21. PubMed ID: 31072670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.
    Riediger H; Keck T; Wellner U; zur Hausen A; Adam U; Hopt UT; Makowiec F
    J Gastrointest Surg; 2009 Jul; 13(7):1337-44. PubMed ID: 19418101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic cystic endocrine tumors: a different morphological entity associated with a less aggressive behavior.
    Boninsegna L; Partelli S; D'Innocenzio MM; Capelli P; Scarpa A; Bassi C; Pederzoli P; Falconi M
    Neuroendocrinology; 2010; 92(4):246-51. PubMed ID: 20689265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgery and staging of pancreatic neuroendocrine tumors: a 14-year experience.
    Ito H; Abramson M; Ito K; Swanson E; Cho N; Ruan DT; Swanson RS; Whang EE
    J Gastrointest Surg; 2010 May; 14(5):891-8. PubMed ID: 20224984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients.
    Ruzzenente A; Capra F; Pachera S; Iacono C; Piccirillo G; Lunardi M; Pistoso S; Valdegamberi A; D'Onofrio M; Guglielmi A
    J Gastrointest Surg; 2009 Jul; 13(7):1313-20. PubMed ID: 19418103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indications for resection and perioperative outcomes of surgery for pancreatic neuroendocrine neoplasms in Germany: an analysis of the prospective DGAV StuDoQ|Pancreas registry.
    Mintziras I; Keck T; Werner J; Fichtner-Feigl S; Wittel U; Senninger N; Vowinkel T; Köninger J; Anthuber M; Geißler B; Bartsch DK;
    Surg Today; 2019 Dec; 49(12):1013-1021. PubMed ID: 31240463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Well or poorly differentiated nonfunctioning neuroendocrine carcinoma of the pancreas: a single institution experience with 17 cases.
    Sellner F; Sobhian B; De Santis M; Pont J; Staettner S; Sellner S; Karner J; Klimpfinger M
    Eur J Surg Oncol; 2008 Feb; 34(2):191-5. PubMed ID: 17475440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nodal counts and lymph node ratio impact survival after distal pancreatectomy for pancreatic adenocarcinoma.
    Ashfaq A; Pockaj BA; Gray RJ; Halfdanarson TR; Wasif N
    J Gastrointest Surg; 2014 Nov; 18(11):1929-35. PubMed ID: 24916590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. En bloc resection for locally advanced cancer of the pancreas: is it worthwhile?
    Sasson AR; Hoffman JP; Ross EA; Kagan SA; Pingpank JF; Eisenberg BL
    J Gastrointest Surg; 2002; 6(2):147-57; discussion 157-8. PubMed ID: 11992799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resection strategies for neuroendocrine pancreatic neoplasms.
    Watzka FM; Laumen C; Fottner C; Weber MM; Schad A; Lang H; Musholt TJ
    Langenbecks Arch Surg; 2013 Mar; 398(3):431-40. PubMed ID: 23143147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical Treatment as a Principle for Patients with High-Grade Pancreatic Neuroendocrine Carcinoma: A Nordic Multicenter Comparative Study.
    Haugvik SP; Janson ET; Österlund P; Langer SW; Falk RS; Labori KJ; Vestermark LW; Grønbæk H; Gladhaug IP; Sorbye H
    Ann Surg Oncol; 2016 May; 23(5):1721-8. PubMed ID: 26678407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic Cancer Surgery: The New R-status Counts.
    Strobel O; Hank T; Hinz U; Bergmann F; Schneider L; Springfeld C; Jäger D; Schirmacher P; Hackert T; Büchler MW
    Ann Surg; 2017 Mar; 265(3):565-573. PubMed ID: 27918310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgery for Pancreatic Neuroendocrine Tumor G3 and Carcinoma G3 Should be Considered Separately.
    Yoshida T; Hijioka S; Hosoda W; Ueno M; Furukawa M; Kobayashi N; Ikeda M; Ito T; Kodama Y; Morizane C; Notohara K; Taguchi H; Kitano M; Yane K; Tsuchiya Y; Komoto I; Tanaka H; Tsuji A; Hashigo S; Mine T; Kanno A; Murohisa G; Miyabe K; Takagi T; Matayoshi N; Sakaguchi M; Ishii H; Kojima Y; Matsuo K; Yoshitomi H; Nakamori S; Yanagimoto H; Yatabe Y; Furuse J; Mizuno N
    Ann Surg Oncol; 2019 May; 26(5):1385-1393. PubMed ID: 30863939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonfunctioning neuroendocrine pancreatic tumors: our experience and management.
    Nomura N; Fujii T; Kanazumi N; Takeda S; Nomoto S; Kasuya H; Sugimoto H; Yamada S; Nakao A
    J Hepatobiliary Pancreat Surg; 2009; 16(5):639-47. PubMed ID: 19365596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parenchyma-sparing resections for pancreatic neuroendocrine tumors.
    Cherif R; Gaujoux S; Couvelard A; Dokmak S; Vuillerme MP; Ruszniewski P; Belghiti J; Sauvanet A
    J Gastrointest Surg; 2012 Nov; 16(11):2045-55. PubMed ID: 22911124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopathological features of pancreatic neuroendocrine neoplasms: a retrospective analysis of 64 cases].
    Yao W; Wang W; Li G
    Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):287-93. PubMed ID: 24989916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.